Sarah Ayton

Sarah Ayton is an accomplished Principal Scientist at Genesis Research Group specializing in Real World Evidence, with extensive experience leading cross-functional teams in oncology, neurology, and immunology. At Columbia University Mailman School of Public Health, Sarah serves as an Instructor for graduate-level biostatistics, employing innovative teaching methods to enhance student engagement. Sarah's notable research background includes pioneering studies on HIV risk in South Africa and multi-omics cancer subtyping, supported by funding from prestigious organizations. With a Doctor of Philosophy in Computer Science and a Master of Public Health in Epidemiology, Sarah combines advanced statistical expertise and technical skills to drive impactful research and education in public health and biostatistics.